Systemic Inflammation Differences in Brain-vs. Circulatory-Dead Donors: Impact on Lung Transplant Recipients.


Journal

Transplant international : official journal of the European Society for Organ Transplantation
ISSN: 1432-2277
Titre abrégé: Transpl Int
Pays: Switzerland
ID NLM: 8908516

Informations de publication

Date de publication:
2024
Historique:
received: 04 12 2023
accepted: 17 05 2024
medline: 18 6 2024
pubmed: 18 6 2024
entrez: 18 6 2024
Statut: epublish

Résumé

Brain death triggers a systemic inflammatory response. Whether systemic inflammation is different in lung donors after brain- (DBD) or circulatory-death (DCD) is unknown, but this may potentially increase the incidence of primary graft dysfunction (PGD) after lung transplantation. We compared the plasma levels of interleukin (IL)-6, IL-8, IL-10 and TNF-α in BDB and DCD and their respective recipients, as well as their relationship with PGD and mortality after LT. A prospective, observational, multicenter, comparative, cohort-nested study that included 40 DBD and 40 DCD lung donors matched and their respective recipients. Relevant clinical information and blood samples were collected before/during lung retrieval in donors and before/during/after (24, 48 and 72 h) LT in recipients. Incidence of PGD and short-term mortality after LT was recorded. Plasma levels of all determined cytokines were numerically higher in DBD than in DCD donors and reached statistical significance for IL-6, IL-10 and IL-8. In recipients with PGD the donor's plasma levels of TNF-α were higher. The post-operative mortality rate was very low and similar in both groups. DBD is associated with higher systemic inflammation than DCD donors, and higher TNF-α plasma levels in donors are associated with a higher incidence of PGD.

Identifiants

pubmed: 38887494
doi: 10.3389/ti.2024.12512
pii: 12512
pmc: PMC11182341
doi:

Substances chimiques

Tumor Necrosis Factor-alpha 0
Interleukin-10 130068-27-8
Interleukin-6 0
Interleukin-8 0
Cytokines 0

Types de publication

Journal Article Multicenter Study Observational Study Comparative Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

12512

Informations de copyright

Copyright © 2024 Sandiumenge, Bello, Coll-Torres, Gomez-Brey, Franco-Jarava, Miñambres, Pérez-Redondo, Mosteiro, Sánchez-Moreno, Crowley, Fieira, Suberviola, Mazo, Agustí and Pont.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Am J Transplant. 2007 Jan;7(1):83-90
pubmed: 17227559
Proc Am Thorac Soc. 2009 Jan 15;6(1):39-46
pubmed: 19131529
Rev Bras Ter Intensiva. 2019;31(1):86-92
pubmed: 30916235
J Heart Lung Transplant. 2021 Sep;40(9):890-896
pubmed: 34167864
J Heart Lung Transplant. 2011 Mar;30(3):289-98
pubmed: 21093300
Semin Respir Crit Care Med. 2013 Jun;34(3):305-319
pubmed: 23821506
Transplant Proc. 2007 Sep;39(7):2425-6
pubmed: 17889209
J Heart Lung Transplant. 1992 Nov-Dec;11(6):1017-24
pubmed: 1457425
Arch Bronconeumol. 2009 Jan;45(1):12-5
pubmed: 19186293
Transpl Int. 2016 Nov;29(11):1237-1246
pubmed: 27514498
Am J Respir Crit Care Med. 2001 Jan;163(1):259-65
pubmed: 11208654
Ann Thorac Surg. 2018 Jun;105(6):1763-1770
pubmed: 29382512
J Heart Lung Transplant. 2019 Oct;38(10):1042-1055
pubmed: 31548030
J Heart Lung Transplant. 2004 Sep;23(9 Suppl):S217-22
pubmed: 15381167
J Heart Lung Transplant. 2017 Oct;36(10):1097-1103
pubmed: 28942784
BMJ Open. 2017 Jun 30;7(6):e014436
pubmed: 28667204
Am J Respir Crit Care Med. 2003 Feb 15;167(4):490-511
pubmed: 12588712
Ann Thorac Surg. 2006 May;81(5):1844-9; discussion 1849-50
pubmed: 16631683
Eur Respir J. 2021 Apr 22;57(4):
pubmed: 33122335
Transplantation. 1999 Feb 15;67(3):343-8
pubmed: 10030276

Auteurs

Alberto Sandiumenge (A)

Donation and Trasplantation Program Coordination Unit, Vall d'Hebron, University Hospital, Cell, Tissue and Organ Donation and Trasplantation Resarch Group, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.

Irene Bello (I)

Department of Thoracic Surgery, Respiratory Institute Hospital Clínic, Barcelona, Spain.
Institut d'Investigacions BIomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

Elisabeth Coll-Torres (E)

Medical Department, Organización Nacional de Trasplantes, Madrid, Spain.

Aroa Gomez-Brey (A)

Donation and Trasplantation Program Coordination Unit, Vall d'Hebron, University Hospital, Cell, Tissue and Organ Donation and Trasplantation Resarch Group, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.

Clara Franco-Jarava (C)

Immunology Department, Vall d'Hebron University Hospital, Barcelona, Spain.

Eduardo Miñambres (E)

Transplant Coordination Unit and Department of Intensive Care, University Hospital Marqués de Valdecilla-IDIVAL, School of Medicine, University of Cantabria, Santander, Spain.

Marina Pérez-Redondo (M)

Departament of Critical Care, Department of Donor and Transplant Coordinator, Puerta de Hierro Majadahonda University Hospital, Madrid, Spain.

Fernando Mosteiro (F)

Departament of Critical Care, Department of Donor and Transplant Coordinator, A Coruña University Hospital, A Coruña, Spain.

Laura Sánchez-Moreno (L)

Department of Thoracic Surgery, University Hospital Marqués de Valdecilla-IDIVAL, School of Medicine, University of Cantabria, Santander, Spain.

Silvana Crowley (S)

Department of Thoracic Surgery and Lung Trasplantation, Puerta de Hierro Majadahonda University Hospital, Madrid, Spain.

Eva Fieira (E)

Department of Thoracic Surgery and Lung Trasplantation, A Coruña University Hospital, A Coruña, Spain.

Borja Suberviola (B)

Transplant Coordination Unit and Department of Intensive Care, University Hospital Marqués de Valdecilla-IDIVAL, School of Medicine, University of Cantabria, Santander, Spain.

Cristopher Alan Mazo (CA)

Donation and Trasplantation Program Coordination Unit, Vall d'Hebron, University Hospital, Cell, Tissue and Organ Donation and Trasplantation Resarch Group, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.

Alvar Agustí (A)

Institut d'Investigacions BIomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Department of Pneumology, Respiratory Institute, Barcelona, Spain.
Cátedra de Salut Respiratoria, Universidad de Barcelona, Barcelona, Spain.
CIBER Enfermedades Respiratorias (CIBERES), Madrid, Spain.

Teresa Pont (T)

Donation and Trasplantation Program Coordination Unit, Vall d'Hebron, University Hospital, Cell, Tissue and Organ Donation and Trasplantation Resarch Group, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH